Publication:
Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort

dc.contributor.authorsOmma, A.; Erer, B.; Karadag, O.; Yilmaz, N.; Alibaz-Oner, F.; Yildiz, F.; Kalfa, M.; Kimyon, G.; Kiraz, S.; Direskeneli, H.; Erken, E.; Aksu, K.; Onat, A. M.; Gul, A.; Ocal, L.; Inanc, M.; Kamali, S.
dc.date.accessioned2022-03-12T22:24:08Z
dc.date.accessioned2026-01-11T17:32:54Z
dc.date.available2022-03-12T22:24:08Z
dc.date.issued2017
dc.description.abstractObjective. We aimed to assess the outcome of a large Takayasu arteritis (TAK) cohort using the vasculitis damage index (VDI) and quality of life (QoL) scale, tools which have been validated for vasculitis. Methods. Disease activity, damage and QoL were cross-sectionally evaluated in 165 TAK patients from 6 centres. SF-36 were applied to 51 age-matched healthy controls (HC). Persistent activity for months was considered as treatment resistance (r-TAK). The correlation between VDI, clinical characteristics and mental (MCS)/physical (PCS) component scores of SF-36 were analysed. SF-36 and VDI scores were compared between TAK subgroups and HC. Results. The median age, follow-up time and disease duration were 40 (17-68), 60 (6-384), and 72 (6-396) months, respectively. 35% of them were r-TAK. VDI scores (VDIs) in TAK 4 (1-12) were mainly due to the disease itself [4 (1-10)]. VDIs in r-TAK were significantly higher than nr-TAK [5 (212) vs. 3 (2-10), p<0.001)1. In the TAK patients, MCS and PCS were found as 43 10 and 38 11, respectively. A high proportion of poor MCS (70%) and PCS (80%) were demonstrated in TAK. A significantly negative but weak correlation was observed between VDI and MCS (p=0.003, r=-0.23), PCS (p<0.001, r=-0.34). Higher VDIs were detected in patients with PCS <50 [5 (.1-12) vs. 2 (1-6) p<0.001)]. SF-36 score was significantly lower in TAK than KC. Conclusion. Disease-related damage mainly caused by peripheral vascular involvement was more predominant than treatment-related damage without reaching the level of severe damage scores, but contributing to poor QoL, in the TAK cohort.
dc.identifier.doidoiWOS:000402448900010
dc.identifier.eissn1593-098X
dc.identifier.issn0392-856X
dc.identifier.pubmed27908308
dc.identifier.urihttps://hdl.handle.net/11424/234683
dc.identifier.wosWOS:000402448900010
dc.language.isoeng
dc.publisherCLINICAL & EXPER RHEUMATOLOGY
dc.relation.ispartofCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectvasculitis
dc.subjectTakayasu arteritis
dc.subjectvasculitis damage index
dc.subjectquality of life
dc.subjectANTIBODY-ASSOCIATED VASCULITIS
dc.subjectHEALTH SURVEY SF-36
dc.subjectWEGENERS-GRANULOMATOSIS
dc.subjectSYSTEMIC VASCULITIS
dc.subjectMENTAL-HEALTH
dc.subjectDISABILITY
dc.subjectSURVIVAL
dc.subjectAORTITIS
dc.subjectVALIDITY
dc.subjectDISEASE
dc.titleRemarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPageS82
oaire.citation.issue1
oaire.citation.startPageS77
oaire.citation.titleCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
oaire.citation.volume35

Files